|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Concert Pharmaceuticals, Inc. (CNCE) |
|
|
$8.37 0.00 (0.00%) as of 4:30 Fri 3/3
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
47,940,000 |
| Market
Cap: |
401.26(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.37 - $8.37 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company that is developing CTP-543, a Janus Kinase 1 and Janus Kinase 2 inhibitor that Co. discovered through the application of its DCE Platform® (deuterated chemical entity platform). Co. is evaluating CTP-543 in a Phase 3 clinical program for the treatment of alopecia areata, a serious autoimmune dermatological condition. In addition to its wholly-owned development programs, Co. has entered into collaborative arrangements with companies to develop deuterium-modified versions of their marketed products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
227,052 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,078,498 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
81,977 |
| Total Sell Value |
$0 |
$0 |
$0 |
$653,253 |
| Total People Sold |
0 |
0 |
0 |
6 |
| Total Sell Transactions |
0 |
0 |
0 |
14 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tung Roger D |
Chief Executive Officer |
• • – |
2019-12-04 |
4 |
OE |
$4.41 |
$58,062 |
D/D |
13,166 |
644,686 |
|
- |
|
| Stuart Nancy |
Chief Operating Officer |
• – – |
2019-12-04 |
4 |
D |
$7.61 |
$25,996 |
D/D |
(3,416) |
101,323 |
|
- |
|
| Stuart Nancy |
Chief Operating Officer |
• – – |
2019-12-04 |
4 |
OE |
$4.41 |
$26,001 |
D/D |
5,896 |
104,739 |
|
- |
|
| Van Heek Christi |
Director |
– • – |
2019-10-08 |
4 |
B |
$5.90 |
$29,504 |
D/D |
5,000 |
10,000 |
2.39 |
- |
|
| Becker Marc A. |
CFO, PFO |
• – – |
2019-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
28,093 |
28,093 |
|
- |
|
| Cassella James V |
Chief Development Officer |
• – – |
2019-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
31,100 |
52,265 |
|
- |
|
| Lynch Ryan |
PAO |
• – – |
2019-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
14,063 |
18,059 |
|
- |
|
| Hutt Peter Barton |
Director |
– • – |
2019-08-08 |
4 |
S |
$10.31 |
$36,487 |
D/D |
(3,539) |
4,424 |
|
- |
|
| Hutt Peter Barton |
Director |
– • – |
2019-08-08 |
4 |
OE |
$4.41 |
$15,607 |
D/D |
3,539 |
7,963 |
|
- |
|
| Van Heek Christi |
Director |
– • – |
2019-08-02 |
4 |
B |
$10.84 |
$54,203 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| Lampert Mark N |
10% Owner |
– – • |
2019-06-10 |
4 |
S |
$10.70 |
$4,134,799 |
D/D |
(386,289) |
169,589 |
|
- |
|
| Tung Roger D |
Chief Executive Officer |
• • – |
2019-04-10 |
4 |
OE |
$4.41 |
$109,747 |
D/D |
24,886 |
616,919 |
|
- |
|
| Lampert Mark N |
10% Owner |
– – • |
2019-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,687,641 |
|
- |
|
| Cassella James V |
Chief Development Officer |
• – – |
2019-03-31 |
4 |
D |
$12.07 |
$106,638 |
D/D |
(8,835) |
21,165 |
|
- |
|
| Lynch Ryan |
PAO |
• – – |
2019-03-31 |
4 |
D |
$12.07 |
$12,589 |
D/D |
(1,043) |
3,996 |
|
- |
|
| Stuart Nancy |
Chief Operating Officer |
• – – |
2019-03-31 |
4 |
D |
$12.07 |
$106,638 |
D/D |
(8,835) |
98,843 |
|
- |
|
| Tung Roger D |
Chief Executive Officer |
• • – |
2019-03-31 |
4 |
D |
$12.07 |
$71,092 |
D/D |
(5,890) |
592,033 |
|
- |
|
| Stuart Nancy |
Chief Operating Officer |
• – – |
2019-02-06 |
4 |
D |
$13.95 |
$126,192 |
D/D |
(9,046) |
107,678 |
|
- |
|
| Stuart Nancy |
Chief Operating Officer |
• – – |
2019-02-06 |
4 |
OE |
$4.41 |
$126,197 |
D/D |
28,616 |
116,724 |
|
- |
|
| Stuart Nancy |
Chief Operating Officer |
• – – |
2018-11-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,850 |
88,108 |
|
- |
|
| Auchincloss Thomas G |
Director |
– • – |
2018-11-15 |
4 |
B |
$11.50 |
$11,500 |
D/D |
1,000 |
4,000 |
2.39 |
- |
|
| Stuart Nancy |
Chief Operating Officer |
• – – |
2018-07-10 |
4 |
AS |
$17.94 |
$468,697 |
D/D |
(26,127) |
89,958 |
|
- |
|
| Stuart Nancy |
Chief Operating Officer |
• – – |
2018-07-09 |
4 |
AS |
$17.56 |
$92,890 |
D/D |
(5,291) |
116,085 |
|
- |
|
| Tung Roger D |
Chief Executive Officer |
• • – |
2018-06-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
597,923 |
|
- |
|
| Cassella James V |
Chief Development Officer |
• – – |
2018-04-17 |
4 |
AS |
$20.18 |
$213,510 |
D/D |
(10,582) |
30,000 |
|
- |
|
279 Records found
|
|
Page 5 of 12 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
